Get started
Author

Yan Lin

Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi
2018 · Shawn Tahata, Shivendra V. Singh, et al. · Cancer Prevention Research · 86
Final results of a phase 1 study of single-agent veliparib (V) in patients (pts) with either BRCA1/2-mutated cancer (BRCA+), platinum-refractory ovarian, or basal-like breast cancer (BRCA-wt).
2014 · Shannon Puhalla, Jan Hendrik Beumer, et al. · Journal of Clinical Oncology · 63
Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions
2015 · Joel L. Weissfeld, Yan Lin, et al. · Journal of Thoracic Oncology · 42
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
2019 · Leonard J. Appleman, Jan H. Beumer, et al. · Cancer Chemotherapy and Pharmacology · 39
Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome
2015 · Jill M. Siegfried, Yan Lin, et al. · Neoplasia · 30
PDF
A phase I study of veliparib (ABT-888) in combination with weekly carboplatin and paclitaxel in advanced solid malignancies and enriched for triple-negative breast cancer (TNBC).
2015 · Shalu Pahuja, Jan Hendrik Beumer, et al. · Journal of Clinical Oncology · 29
Effect of Renal Dysfunction on Toxicity in Three Decades of Cancer Therapy Evaluation Program–Sponsored Single-Agent Phase I Studies
2015 · Jan H. Beumer, Fei Ding, et al. · Journal of Clinical Oncology · 28
Identification of PARP-1 as one of the transcription factors binding to the repressor element in the promoter region of COX-2
2010 · Yan Lin, Xinyi Tang, et al. · Archives of Biochemistry and Biophysics · 24
Enhancing photothermal therapy of tumors with image-guided thermal control of gene-expressing bacteria
2024 · Fengyi Zeng, Meng Du, et al. · Theranostics · 22
A phase I study of chronically dosed, single-agent veliparib (ABT-888) in patients (pts) with either BRCA 1/2-mutated cancer (BRCA+), platinum-refractory ovarian cancer, or basal-like breast cancer (BRCA-wt).
2012 · Shannon Leigh Huggins-Puhalla, Jan Hendrik Beumer, et al. · Journal of Clinical Oncology · 20
A phase I study of veliparib (ABT-888) in combination with carboplatin and paclitaxel in advanced solid malignancies.
2012 · Leonard Joseph Appleman, Jan Hendrik Beumer, et al. · Journal of Clinical Oncology · 20
Phase I study of veliparib in combination with gemcitabine
2017 · Ronald Stoller, John C. Schmitz, et al. · Cancer Chemotherapy and Pharmacology · 13
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
2022 · Julia Manzo, Shannon Puhalla, et al. · Cancer Chemotherapy and Pharmacology · 10
Targeted next-generation sequencing identified ADAMTS5 as novel genetic substrate in patients with bicuspid aortic valve
2017 · Xiaoping Lin, Xianbao Liu, et al. · International Journal of Cardiology · 10
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)
2023 · Monica K. Malhotra, Shalu Pahuja, et al. · Breast Cancer Research and Treatment · 8
PDF
Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers
2013 · Hussein A. Tawbi, An L. Tran, et al. · Cancer Chemotherapy and Pharmacology · 7
Calcium carbonate does not affect imatinib pharmacokinetics in healthy volunteers
2013 · Hussein Tawbi, Susan M. Christner, et al. · Cancer Chemotherapy and Pharmacology · 3
Early phase I study of the PARP inhibitor veliparib (ABT-888) alone or in combination with carboplatin/paclitaxel (CP) in patients with varying degrees of hepatic or renal dysfunction: A study of the NCI-Organ Dysfunction Working Group (ODG).
2014 · Hussein Abdul-Hassan Tawbi, Edward Chu, et al. · Journal of Clinical Oncology · 2
Surveillance for melanoma (MEL): Results of a database study of stage I-III MEL.
2018 · Corey Rearick, Fei Ding, et al. · Journal of Clinical Oncology · 1
Research of tricuspid regurgitation associated with cardiac implantable electronic devices
2025 · Danqing YU, Yan LIN, et al. · Journal of Zhejiang University (Medical Sciences)
PDF
Abstract 5499: Temozolomide (TMZ) cytotoxicity in human melanoma cell lines is enhanced by concomitant treatment with the histone deacetylase (HDAC) inhibitor vorinostat (SAHA) and PARP inhibitor MK-4827
2011 · Hussein Tawbi, John M. Kirkwood, et al. · Cancer Research
Works count: 21
Citation count: 457
H-index: 12
I10-index: 14
Year
Topic
Type